What Happened?
New York, AB-based LEXEO-Therapeutics Appointed Nolan Townsend as Chief Executive Officer
About the Company
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases.
About the Person
Nolan Townsend is Chief Executive Officer at LEXEO Therapeutics. Previously, Nolan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile